Aduhelm

aducanumab · Biogen

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Aduhelm, covering 2022-08-01 to 2025-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease [Phase 3]